Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)

Naoko Hashimoto Takigami; Shimpei Kuniyoshi; Yasuhiro Miki; Kentaro Tamaki; Yoshihiko Kamada; Kano Uehara; Seiko Tsuchiya; Shigeharu Terukina; Erina Iwabuchi; Ayako Kanai; Minoru Miyashita; Takanori Ishida; Nobumitsu Tamaki; Hironobu Sasano

doi:10.1007/s10549-021-06380-8

Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)

Naoko Hashimoto Takigami, Shimpei Kuniyoshi, Yasuhiro Miki, Kentaro Tamaki, Yoshihiko Kamada, Kano Uehara, Seiko Tsuchiya, Shigeharu Terukina, Erina Iwabuchi, Ayako Kanai, Minoru Miyashita, Takanori Ishida, Nobumitsu Tamaki, Hironobu Sasano

研究成果: Comment/debate › 査読

抄録

In the original publication of the article, the antibody against GLP-1R which we used in this study was not mouse monoclonaly ab166987 as reported in the manuscript but rabbit polyclonal ab188602, both commercially obtained from Abcam.

本文言語	English
ページ（範囲）	221
ページ数	1
ジャーナル	Breast Cancer Research and Treatment
巻	191
号	1
DOI	https://doi.org/10.1007/s10549-021-06380-8
出版ステータス	Published - 2022 1月

ASJC Scopus subject areas

腫瘍学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1007/s10549-021-06380-8

他のファイルとリンク

フィンガープリント

「Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Hashimoto Takigami, N., Kuniyoshi, S., Miki, Y., Tamaki, K., Kamada, Y., Uehara, K., Tsuchiya, S., Terukina, S., Iwabuchi, E., Kanai, A., Miyashita, M., Ishida, T., Tamaki, N., & Sasano, H. (2022). Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3). Breast Cancer Research and Treatment, 191(1), 221. https://doi.org/10.1007/s10549-021-06380-8

Correction to : Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3). / Hashimoto Takigami, Naoko; Kuniyoshi, Shimpei; Miki, Yasuhiro その他.

In: Breast Cancer Research and Treatment, Vol. 191, No. 1, 01.2022, p. 221.

研究成果: Comment/debate › 査読

Hashimoto Takigami, N, Kuniyoshi, S, Miki, Y, Tamaki, K, Kamada, Y, Uehara, K, Tsuchiya, S, Terukina, S, Iwabuchi, E, Kanai, A, Miyashita, M , Ishida, T, Tamaki, N & Sasano, H 2022, 'Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)', Breast Cancer Research and Treatment, vol. 191, no. 1, pp. 221. https://doi.org/10.1007/s10549-021-06380-8

Hashimoto Takigami N, Kuniyoshi S, Miki Y, Tamaki K, Kamada Y, Uehara K その他. Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3). Breast Cancer Research and Treatment. 2022 1月;191(1):221. doi: 10.1007/s10549-021-06380-8

Hashimoto Takigami, Naoko ; Kuniyoshi, Shimpei ; Miki, Yasuhiro その他. / Correction to : Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3). In: Breast Cancer Research and Treatment. 2022 ; Vol. 191, No. 1. pp. 221.

@article{f9fecd8a58684aa2a06445d8f56cbcb4,

title = "Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)",

abstract = "In the original publication of the article, the antibody against GLP-1R which we used in this study was not mouse monoclonaly ab166987 as reported in the manuscript but rabbit polyclonal ab188602, both commercially obtained from Abcam.",

author = "{Hashimoto Takigami}, Naoko and Shimpei Kuniyoshi and Yasuhiro Miki and Kentaro Tamaki and Yoshihiko Kamada and Kano Uehara and Seiko Tsuchiya and Shigeharu Terukina and Erina Iwabuchi and Ayako Kanai and Minoru Miyashita and Takanori Ishida and Nobumitsu Tamaki and Hironobu Sasano",

note = "Publisher Copyright: {\textcopyright} 2021, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2022",

month = jan,

doi = "10.1007/s10549-021-06380-8",

language = "English",

volume = "191",

pages = "221",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)

AU - Hashimoto Takigami, Naoko

AU - Kuniyoshi, Shimpei

AU - Miki, Yasuhiro

AU - Tamaki, Kentaro

AU - Kamada, Yoshihiko

AU - Uehara, Kano

AU - Tsuchiya, Seiko

AU - Terukina, Shigeharu

AU - Iwabuchi, Erina

AU - Kanai, Ayako

AU - Miyashita, Minoru

AU - Ishida, Takanori

AU - Tamaki, Nobumitsu

AU - Sasano, Hironobu

PY - 2022/1

Y1 - 2022/1

N2 - In the original publication of the article, the antibody against GLP-1R which we used in this study was not mouse monoclonaly ab166987 as reported in the manuscript but rabbit polyclonal ab188602, both commercially obtained from Abcam.

AB - In the original publication of the article, the antibody against GLP-1R which we used in this study was not mouse monoclonaly ab166987 as reported in the manuscript but rabbit polyclonal ab188602, both commercially obtained from Abcam.

UR - http://www.scopus.com/inward/record.url?scp=85116327042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116327042&partnerID=8YFLogxK

U2 - 10.1007/s10549-021-06380-8

DO - 10.1007/s10549-021-06380-8

M3 - Comment/debate

C2 - 34606001

AN - SCOPUS:85116327042

SN - 0167-6806

VL - 191

SP - 221

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 1

ER -